SAN FRANCISCO (AP) - Yahoo is taking the next step in its effort to make some of its most popular services more appealing and accessible to the growing audience connecting to the Internet on smartphones and tablet computers.
NEW YORK (AP) - Microsoft is working with manufacturers to produce a line of small touch-screen devices powered by Windows, apparently intended to compete with 7-inch tablets like the iPad Mini and Amazon Kindle Fire.
SANTA MONICA, Calif. (AP) - There used to be just one way for getting shows on TV. Networks would spend tens of millions of dollars ordering scripts and shooting pilots and then show the fruits of their labor to focus groups. A small group of executives would cherry-pick a few promising shows to put on TV, hoping they'd be a hit with bigger audiences.
DALLAS (AP) - A key computer system used to run many daily operations at American Airlines failed Tuesday, forcing the nation's third-largest carrier to ground all flights across the United States for several hours and stranding thousands of frustrated passengers at airports and on planes.
NEW YORK (AP) - As J.C. Penney Co. burns through its cash after a disastrous turnaround plan and taps almost half of its credit line, the flailing department store chain doesn't only have to calm its investors. It has to restore confidence among its several hundred suppliers whose constant flow of merchandise must continue if the retailer is to survive.
NEW YORK (AP) - Dish Network Corp. is trying to snag U.S. wireless carrier Sprint Nextel away from a Japanese suitor, the latest sign that satellite dishes are losing their relevance in the age of cellphones that play everything from YouTube videos to live TV.
SAN FRANCISCO (AP) - Did the National Security Agency plant spyware deep in the hard drives of thousands of computers used by foreign governments, banks and other surveillance targets around the world?
WASHINGTON (AP) - The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women's groups and consumer advocates will move their much-debated drug onto the market.